0001209191-20-021888.txt : 20200331 0001209191-20-021888.hdr.sgml : 20200331 20200331173714 ACCESSION NUMBER: 0001209191-20-021888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200327 FILED AS OF DATE: 20200331 DATE AS OF CHANGE: 20200331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ledda Ralf CENTRAL INDEX KEY: 0001690024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 20762996 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-27 0 0000742112 INVACARE CORP IVC 0001690024 Ledda Ralf ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Sen VP/GM-EUR,Mid East&Africa Common Shares 2020-03-27 4 A 0 10512 0.00 A 82141 D Employee Stock Option (Right to Buy) Common Shares 53733 53733 D Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2021. Includes 19,100 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 2,432 of these restricted stock units vest on May 15, 2020; 3,360 of these restricted stock units vest in 1/2 increments on May 15, 2020 and May 15, 2021; and 13,308 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2020. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5. The reporting person holds previously reported options to buy 53,733 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 18, 2010 and March 16, 2017, at exercise prices between $12.15 to $25.24 per share, will expire between August 18, 2020 and March 16, 2027, and became exercisable between September 30, 2011 and February 19, 2020. /s/ Ralf Ledda, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated November 10, 2016, on file with the Commission 2020-03-31